
1. malar j. 2017 jul 3;16(1):263. doi: 10.1186/s12936-017-1911-z.

new gorilla adenovirus vaccine vectors induce potent immune responses and
protection mouse malaria model.

limbach k(1)(2), stefaniak m(1)(2), chen p(3), patterson nb(1)(2), liao g(3),
weng s(3), krepkiy s(3), ekberg g(3), torano h(3), ettyreddy d(3), gowda k(1),
sonawane s(1)(2), belmonte a(1)(2), abot e(1)(2), sedegah m(1), hollingdale
mr(1)(2), moormann a(4), vulule j(5), villasante e(1), richie tl(1), brough
de(3), bruder jt(6).

author information: 
(1)malaria department, naval medical research center, 503 robert grant avenue,
silver spring, md, usa.
(2)henry m. jackson foundation advancement military medicine, inc.,
6720a rockledge drive, suite 100, bethesda, md, usa.
(3)genvec incorporated, 910 clopper road, suite 220n, gaithersburg, md, usa.
(4)university massachusetts medical school, worcester, ma, usa.
(5)center global health research, kenya medical research institute, kisumu,
kenya.
(6)genvec incorporated, 910 clopper road, suite 220n, gaithersburg, md, usa.
joetbruder@gmail.com.

background: dna-human ad5 (huad5) prime-boost malaria vaccine shown to
protect volunteers controlled human malaria infection. potency of
this vaccine, however, appeared affected presence pre-existing
immunity huad5 vector. since huad5 seroprevalence high in
malaria-endemic areas world, huad5 may appropriate malaria
vaccine vector. report describes evaluation seroprevalence,
immunogenicity efficacy three newly identified gorilla adenoviruses, gc44,
gc45 gc46, potential malaria vaccine vectors.
results: seroprevalence gc44, gc45 gc46 low, three
vectors efficiently neutralized human sera kenya ghana, two
countries malaria endemic. mice, single administration gc44,
gc45 gc46 vectors expressing murine malaria gene, plasmodium yoelii
circumsporozoite protein (pycsp), induced robust pycsp-specific cell and
antibody responses least high comparable huad5-pycsp vector.
efficacy studies murine malaria model indicated prime-boost regimen
with dna-pycsp gc-pycsp vectors protect mice malaria challenge.
moreover, studies indicated dna-gc46-pycsp vaccine regimen was
significantly efficacious dna-huad5-pycsp regimen.
conclusion: data suggest gorilla-based adenovectors key
performance characteristics effective malaria vaccine. superior
performance gc46 huad5 highlights potential clinical development.

doi: 10.1186/s12936-017-1911-z 
pmcid: pmc5496260
pmid: 28673287  [indexed medline]

